$19.04
0[0.00%]
Last update: 4:00PM Get Real Time Here
Sage Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Sage Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
04/30/2024 | AM | SAGE | Q1 | -$2.46 | -$1.60 | — | — | $3.29M | $5.97M | — | — | Get Alert |
02/14/2024 | AM | SAGE | Q4 | -$2.47 | -$1.28 | -$0.55 | 57.03% | $2.87M | $60.98M | $77.97M | 27.86% | Get Alert |
11/07/2023 | AM | SAGE | Q3 | -$2.31 | -$2.73 | -$3.37 | -23.44% | $1.74M | $4.62M | $2.72M | -41.21% | Get Alert |
08/07/2023 | AM | SAGE | Q2 | -$2.13 | -$2.55 | -$2.68 | -5.10% | $1.50M | $2.94M | $2.47M | -15.85% | Get Alert |
05/02/2023 | AM | SAGE | Q1 | -$2.07 | -$2.50 | -$2.46 | 1.60% | $1.58M | $2.41M | $3.29M | 36.68% | Get Alert |
02/16/2023 | AM | SAGE | Q4 | -$2.12 | -$2.39 | -$2.47 | -3.35% | $1.64M | $1.94M | $2.87M | 47.68% | Get Alert |
11/08/2022 | AM | SAGE | Q3 | -$2.21 | -$2.21 | -$2.31 | -4.52% | $1.44M | $1.64M | $1.74M | 6.04% | Get Alert |
08/02/2022 | AM | SAGE | Q2 | -$1.83 | -$2.15 | -$2.13 | 0.93% | $1.64M | $1.76M | $1.50M | -14.72% | Get Alert |
05/03/2022 | AM | SAGE | Q1 | -$1.64 | -$2.04 | -$2.07 | -1.47% | $1.58M | $3.21M | $1.58M | -50.72% | Get Alert |
02/24/2022 | AM | SAGE | Q4 | $18.19 | -$2.17 | -$2.12 | 2.30% | $1.11B | $1.97M | $1.64M | -16.65% | Get Alert |
11/02/2021 | AM | SAGE | Q3 | -$2.03 | -$1.85 | -$2.21 | -19.46% | $1.64M | $1.96M | $1.44M | -26.53% | Get Alert |
08/03/2021 | AM | SAGE | Q2 | -$2.08 | -$1.69 | -$1.83 | -8.28% | $1.09M | $2.01M | $1.64M | -18.26% | Get Alert |
05/04/2021 | AM | SAGE | Q1 | -$2.44 | -$1.91 | -$1.64 | 14.14% | $2.29M | $2.00M | $1.58M | -20.85% | Get Alert |
02/24/2021 | AM | SAGE | Q4 | -$3.25 | -$0.35 | $18.19 | 5297.14% | $1.96M | $55.34M | $1.11M | -98.00% | Get Alert |
11/05/2020 | AM | SAGE | Q3 | -$3.48 | -$2.39 | -$2.03 | 15.06% | $3.57M | $1.86M | $1.64M | -11.88% | Get Alert |
08/10/2020 | AM | SAGE | Q2 | -$3.28 | -$2.66 | -$2.08 | 21.80% | $873.00K | $890.00K | $1.09M | 22.36% | Get Alert |
05/07/2020 | AM | SAGE | Q1 | -$3.37 | -$3.14 | -$2.44 | 22.29% | $465.00K | $2.80M | $2.29M | -18.36% | Get Alert |
02/27/2020 | AM | SAGE | Q4 | -$3.38 | -$3.61 | -$3.25 | 9.97% | $273.00K | $3.68M | $1.96M | -46.74% | Get Alert |
11/12/2019 | AM | SAGE | Q3 | -$2.63 | -$3.36 | -$3.48 | -3.57% | $0.00 | $3.60M | $3.57M | -0.83% | Get Alert |
Sage Therapeutics (SAGE) is scheduled to report earnings on April 30, 2024. The last reported earnings were for reported on February 14, 2024 for Q4.
The Actual EPS was $-0.55, which beat the estimate of $-1.28.
The Actual Revenue was $78M, which beat the estimate of $61M.
Browse earnings estimates, EPS, and revenue on all stocks.